Risk factors in patients with ischemic heart disease admitted to the Hospital de la Fundación Tesãi, Ciudad del Este, Paraguay

Main Article Content

Mélani Rebeca Radice Duré
https://orcid.org/0000-0002-5460-5457
Diana Elisa Bogarín Segovia
https://orcid.org/0000-0003-4584-2562
Diego Samuel Ortigoza Barbudez
https://orcid.org/0000-0002-2340-8477
Paulo José Sosa Corrales
https://orcid.org/0000-0002-4854-6198
Julio César Vargas Romero
https://orcid.org/0000-0002-3659-1135
Romina Paola Radice Duré
https://orcid.org/0000-0001-7363-1725
Jorge Willian Ortíz
https://orcid.org/0000-0003-3719-3953
César Augusto Radice Oviedo
https://orcid.org/0000-0003-2175-6045

Abstract

Introduction: cardiovascular diseases occupy the first place in mortality worldwide, so it is important to know the most frequent risk factors in patients with ischemic heart disease.
Objective: to describe the frequency of risk factors in patients with ischemic heart disease admitted to the Hospital de la Fundación Tesãi, Ciudad del Este, Paraguay.
Methodology: the study design was observational, descriptive, retrospective and cross-sectional, it included 61 patients older than 20 years admitted to the Hospital de la Fundación Tesãi, Ciudad del Este, Paraguay, between March 2018 and March 2019.
Results: the representative age was in the age range of 45 to 64 years in the group of men, and 65 to 74 years in the group of women, with a predominance of males. The most relevant risk factors were arterial hypertension and dyslipidemia. However, smoking was the least frequent.
Conclusion: hypertension and dyslipidemia are the most frequent risk factors.

Article Details

How to Cite
1.
Radice Duré MR, Bogarín Segovia DE, Ortigoza Barbudez DS, Sosa Corrales PJ, Vargas Romero JC, Radice Duré RP, Ortíz JW, Radice Oviedo CA. Risk factors in patients with ischemic heart disease admitted to the Hospital de la Fundación Tesãi, Ciudad del Este, Paraguay. Rev. Nac. (Itauguá) [Internet]. 2021 Jul. 9 [cited 2025 Feb. 23];12(2):61-72. Available from: http://revistadelnacional.com.py/index.php/inicio/article/view/25
Section
Artículo Original

References

World Health Organization. Cardiovascular diseases. 2017. Ginebra, Suiza: WHO. Disponible en: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds).

Alcalá López JE, Maicas Bellido C, Hernández Simón P, Rodríguez Padial L. Cardiopatía isquémica: concepto, clasificación, epidemiología, factores de riesgo, pronóstico y prevención. Med. 2017;12(36):2145-2152. doi: 10.1016/j.med.2017.06.010.

Sharifi-Rad J, Rodrigues CF, Sharopov F, Docea AO, Can Karaca A, Sharifi-Rad M, et al. Diet, lifestyle and cardiovascular diseases: linking pathophysiology to cardioprotective effects of natural bioactive compounds. Int J Environ Res Public Health. 2020;17(7):2326. doi: 10.3390/ijerph17072326.

Paraguay, Ministerio de Salud Pública y Bienestar Social, Dirección General de Vigilancia de La Salud; Lima P, Cañete F. Análisis de la situación de las enfermedades crónicas no transmisibles. 2016. Disponible en: : http://portal.mspbs.gov.py/dvent/analisis-la-situacion-las-enfermedades-cronicas-no-transmisibles/

Lind L. Population-based cardiovascular cohort studies in Uppsala. Ups J Med Sci. 2019;124(1):16-20. doi: 10.1080/03009734.2018.1515282.

Brown JC, Gerhardt TE, Kwon E. Risk Factors For Coronary Artery Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2020. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554410/

Antequera Martín-Portugués I, Sánchez Mesa B, Sánchez Lora FJ. Factores de riesgo cardiovascular en situaciones clínicas específicas: diabetes mellitus, insuficiencia renal, enfermedades inflamatorias crónicas, infecciones crónicas, VIH, edad y sexo. Medicine. 2017;12(42):2503-2508. doi: 10.1016/j.med.2017.10.004.

Salgado Ordóñez F, Sanz Cánovas J, Pacheco Yepes R. Riesgo cardiovascular. Medicine. 2017;12(42):2477-2484. doi: 10.1016/j.med.2017.10.001.

Blázquez Collado LA, De Arriba G. Tratamiento de la hipertensión arterial en situaciones especiales. Medicine. 2015;11(92):5488-5495. doi: 10.1016/j.med.2015.12.002.

Franklin SS, Larson MG, Khan SA, Wong ND, Leip EP, Kannel WB, et al. Does the relation of blood pressure to coronary heart disease risk change with aging?: the Framingham Heart Study. Circulation. 2001;103(9):1245-1249. doi: 10.1161/01.CIR.103.9.1245.

Sato C, Wakabayashi K, Ikeda N, Honda Y, Sato K, Susuki T, et al. Influence of sex on the incidence of potential coronary artery disease and long-term outcomes in asymptomatic patients with diabetes mellitus. IJC Hear Vasc. 2020;27:100504. doi: 10.1016/j.ijcha.2020.100504

Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952. doi: 10.1016 / S0140-6736 (04) 17018-9.

Mandviwala T, Khalid U, Deswal A. Obesity and Cardiovascular Disease: a Risk Factor or a Risk Marker?. Curr Atheroscler Rep. 2016;18(5). doi: 10.1007/s11883-016-0575-4.

Mons U, Müezzinler A, Gellert C, Schöttker B, Abnet CC, Bobak M, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: Meta-analysis of Individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:1-12. doi: 10.1136/bmj.h1551

Dagenais GR, Yi Q, Lonn E, Sleight P, Ostergren J, Yusuf S. Impact of cigarette smoking in high-risk patients participating in a clinical trial. A substudy from the Heart Outcomes Prevention Evaluation (HOPE) trial. Eur J Cardiovasc Prev Rehabil. 2005;12(1):75-81. Disponible en: https://pubmed.ncbi.nlm.nih.gov/15703510/

Asociación Médica Mundial. Declaración de Helsinki de la AMM – Principios éticos para las investigaciones médicas en seres humanos; 2013. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

Hassan A, Jaffe R, Rubinshtein R, Karkabi B, Halon DA, Flugelman MY, et al. Characterization of coronary artery disease in young adults and assessment of long-term outcomes. 2018;20(10):613-618. Disponible en: https://www.ima.org.il/FilesUploadPublic/IMAJ/0/310/155137.pdf

Colósimo FC, Sousa AG de, Silva GS da, Piotto RF, Geraldo Pierin AM. Hipertensão arterial e fatores associados em pessoas submetidas à cirurgia de revascularização do miocárdio. Rev Esc Enferm USO. 2015;49(2):201-208. doi: 10.1590/S0080-623420150000200003.

Morán Salinas AJ, Duarte Fariña RF, Ortiz Galeano I. Frequency of coronary risk factors in patients with acute myocardial infarction in the Cardiology Service of the Hospital de Clínicas. Rev Virtual la Soc Paraguaya Med Interna. 2019;6(2):57-63. doi: 10.18004/rvspmi/2312-3893/2019.06.02.57-063

Silbernagel G, Rein P, Saely CH. Prevalence of type 2 diabetes is higher in peripheral artery disease than in coronary artery disease patients. Diabetes Vasc Dis Res. 2015;12(2):146-149. doi: 10.1177/1479164114560342.

De Lorenzo A, Glerian L, Amaral AC, Reis TB, Lima RSL. “Metabolically healthy” obesity: Prevalence, clinical features and association with myocardial ischaemia. Obes Res Clin Pract. 2017;11(3):315-323. doi: 10.1016/j.orcp.2016.08.009

Paraguay, Ministerio de Salud Pública y Bienestar Social, Dirección de Vigilancia de Enfermedades No Transmisibles. Primera encuesta nacional de factores de riesgo de enfermedades no transmisibles en poblacion general. Asunción: El Ministerio. 2012. Disponible en: http://portal.mspbs.gov.py/dvent/wp-content/uploads/2015/10/Encuesta-Nacional.pdf

Jahangir E, De Schutter A, Lavie CJ. The relationship between obesity and coronary artery disease. Transl Res. 2014;164(4):336-344. doi: 10.1016/j.trsl.2014.03.010.

Al Suwaidi J, Al Habib K, Singh R, Hersi A, Al Nemer K, Asaad N, et al. Tobacco modalities used and outcome in patients with acute coronary syndrome: An observational report. Postgrad Med J. 2012;88(1044):566-574. doi: 10.1136/postgradmedj-2011-130178.

Gellert C, Schöttker B, Müller H, Holleczek B, Brenner H. Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults. Eur J Epidemiol. 2013;28(8):649-658.